US2102712A - Protective cosmetics - Google Patents

Protective cosmetics Download PDF

Info

Publication number
US2102712A
US2102712A US426A US42635A US2102712A US 2102712 A US2102712 A US 2102712A US 426 A US426 A US 426A US 42635 A US42635 A US 42635A US 2102712 A US2102712 A US 2102712A
Authority
US
United States
Prior art keywords
amino
ultra violet
concentrations
protective cosmetics
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US426A
Inventor
Isermann Samuel
John W Orelup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US426A priority Critical patent/US2102712A/en
Application granted granted Critical
Publication of US2102712A publication Critical patent/US2102712A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring

Definitions

  • Our present invention relates to improvements in protective cosmetics. It is well known that over-exposure of the body to direct radiation from' between 2900 and 4500 Angstrom units, is very high, amounting to 17% of all the radiation received. The intensity of the region below 2900 amounts to only 1.8%.
  • a means whichcomprises a filter, such as fused calcium phosphate colored with oxides of nickel and cobalt, which admits only physiologically active rays and rejects the visual and infra red rays.
  • the radiation thru this filter is then measured by means of a suitable photo-electric cell, as for example, a copper oxide cell, connected to a highly sensitive microammeter of low internal resistance.
  • the readings of the microamrneter are directly proportional to the intensity of the ultra violet radiation of wave lengths 2900 to 4000.Ilngstrom.
  • menthyl salicylate shows only absorption of the ultra violet, 1 benzyl salicylate undiluted 17%, benzyl cin- 5 namate 20%.
  • fatty acid as for example stearlc acid or oleic acid or mixtures thereof.
  • An advantage of our improved compounds is that they are substantially odorless and colorless.
  • the compounds substituted in the amino group are practically odorless in contradistinction to those compounds substituted in the carboxyl group which are strongly odorous.
  • the active ingredient which we prefer is benzylamino-ortho-benzoic acid.
  • Also effective are the methyland di-methyl-amino-ortho-benzoic acids; the butyl, propyl, amyl, and higher derivatives: as the lauryl, myristyl, cetyl compounds.
  • a 1% solution of dimethyl amino-benzoic acid is formed in 20% almond oil and 80% mineral oil with color and perfume to suit.
  • Ortho-amino-benzoic acid stearate is prepared as follows: 14 lbs. ortho-amido-benzoic acid is' 5 melted with 30 lbs. stearic acid heated to 80 C. until mass is homogeneous. The product is cooled and pulverized. A 2% solution is thereupon region between 2900 degrees and 4000 degrees Angstrom when, said active ingredient is present in an amount not substantially greater than 5%. 4. A cosmetic effective in thin films to retard ultra violet absorption containing as an active ingredient a fatty acid compound of an amino or substituted amino-ortho-benzoic acid in an oily vehicle in concentrations of less than 5%.
  • a cosmetic eilective in thin flims to retard ultra violet absorption containing as an active ingredient an amino or substituted amino-orthobenzoic acid in an oily vehicle in concentrations of less than 5%.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Description

Patented Dec. 21, 1937 PATENT OFFICE PROTECTIVE COSMETICS Samuel Isermann, Summit, Ernst Ohlsson, Jersey City, and John W. Orelup, Summit, N. J.
No Drawing. Application January 4, 1935,
Serial No. 426
5 Claims.
Our present invention relates to improvements in protective cosmetics. It is well known that over-exposure of the body to direct radiation from' between 2900 and 4500 Angstrom units, is very high, amounting to 17% of all the radiation received. The intensity of the region below 2900 amounts to only 1.8%.
Heretofore, workers in the art have been handicapped by the lack of satisfactory means for quantitativelymeasuring the screening effect of thin films of active materials so that the use of substances heretofore proposed has been based largely on theoretical grounds, it being assumed that those substances which show absorption in the ultra violet region would be practical for the purpose of protecting the skin.
We have devised such a means whichcomprises a filter, such as fused calcium phosphate colored with oxides of nickel and cobalt, which admits only physiologically active rays and rejects the visual and infra red rays. The radiation thru this filter is then measured by means of a suitable photo-electric cell, as for example, a copper oxide cell, connected to a highly sensitive microammeter of low internal resistance.
To test a given substance it is merely necessary. to spread a thin film of the same on the filter, expose the coated filter to the sun and record the reading which is thereupon compared with a reading obtained under the same conditions without the film and in this way a percentage value obtained. The readings of the microamrneter are directly proportional to the intensity of the ultra violet radiation of wave lengths 2900 to 4000.Ilngstrom.
By employing this test, it has been found ,that many substances which have heretofore been proposed, such as benzyl cinnamate, benzyl salicylate, menthyl salicylate, aesculetine, salts of quinine, and umbelliferon, although on theoretical grounds capable of a substantial amount of ultra violet absorption, are practically valueless tensity of the ultra violet in the sun radiation.
when used in a thin film even in concentrations in excess of what could be tolerated by the skin. Thus, in the undiluted state, menthyl salicylate shows only absorption of the ultra violet, 1 benzyl salicylate undiluted 17%, benzyl cin- 5 namate 20%.
As can be seen the use of these compounds would be of no appreciable benefit; moreover, the concentrations required even for this small degree of absorption are too high for practical 10 use. Coating the body with undiluted substances of this type would cause serious physiological disturbances.
After examining a large number of substances, we'have found that in thin films even extremely small quantities of amino and substituted aminoortho-benzoic acids have the remarkable property of absorbing from 50% to 80% of the ultra violet radiation of the sun in the region between 2900 and 4000 Angstrom. Percentage concentrations which are effective are as low as .01%. Of course, larger concentrations may be used, for example, up to 5%. In most cases for an 011 type cosmetic it is necessary to form an oil soluble derivative. This oil soluble derivative may be 5.
produced by uniting the active ingredient with a fatty acid, as for example stearlc acid or oleic acid or mixtures thereof.
An advantage of our improved compounds is that they are substantially odorless and colorless. The compounds substituted in the amino group are practically odorless in contradistinction to those compounds substituted in the carboxyl group which are strongly odorous. The active ingredient which we prefer is benzylamino-ortho-benzoic acid. Also effective are the methyland di-methyl-amino-ortho-benzoic acids; the butyl, propyl, amyl, and higher derivatives: as the lauryl, myristyl, cetyl compounds.
The following examples illustrate the invention:
A 1% solution of dimethyl amino-benzoic acid is formed in 20% almond oil and 80% mineral oil with color and perfume to suit.
III
' Ortho-amino-benzoic acid stearate is prepared as follows: 14 lbs. ortho-amido-benzoic acid is' 5 melted with 30 lbs. stearic acid heated to 80 C. until mass is homogeneous. The product is cooled and pulverized. A 2% solution is thereupon region between 2900 degrees and 4000 degrees Angstrom when, said active ingredient is present in an amount not substantially greater than 5%. 4. A cosmetic effective in thin films to retard ultra violet absorption containing as an active ingredient a fatty acid compound of an amino or substituted amino-ortho-benzoic acid in an oily vehicle in concentrations of less than 5%.
5. A cosmetic eilective in thin flims to retard ultra violet absorption containing as an active ingredient an amino or substituted amino-orthobenzoic acid in an oily vehicle in concentrations of less than 5%.
SAMUEL ISERMANN. JOHN W. ORELUP. ERNST OHLSSON.
US426A 1935-01-04 1935-01-04 Protective cosmetics Expired - Lifetime US2102712A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US426A US2102712A (en) 1935-01-04 1935-01-04 Protective cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US426A US2102712A (en) 1935-01-04 1935-01-04 Protective cosmetics

Publications (1)

Publication Number Publication Date
US2102712A true US2102712A (en) 1937-12-21

Family

ID=21691487

Family Applications (1)

Application Number Title Priority Date Filing Date
US426A Expired - Lifetime US2102712A (en) 1935-01-04 1935-01-04 Protective cosmetics

Country Status (1)

Country Link
US (1) US2102712A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136165A (en) * 1976-04-23 1979-01-23 Henkel Kommanditgesellschaft Auf Aktien Cosmetic preparations with alkoxybenzoic acid esters as inflammation inhibitors and method
FR2526313A1 (en) * 1982-05-05 1983-11-10 Johnson & Johnson Baby Prod COMPOSITIONS SOLAR SCREENS
US4426374A (en) 1977-03-23 1984-01-17 Wheeler William B Sunscreen formulation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136165A (en) * 1976-04-23 1979-01-23 Henkel Kommanditgesellschaft Auf Aktien Cosmetic preparations with alkoxybenzoic acid esters as inflammation inhibitors and method
US4426374A (en) 1977-03-23 1984-01-17 Wheeler William B Sunscreen formulation
FR2526313A1 (en) * 1982-05-05 1983-11-10 Johnson & Johnson Baby Prod COMPOSITIONS SOLAR SCREENS

Similar Documents

Publication Publication Date Title
KR102044236B1 (en) Topical minocycline compositions and methods of using the same
US4137301A (en) Method of inhibiting skin irritation
GB2050825A (en) Creamy or milky skin cosmetic compositions
Warshaw et al. Studies of skin reactions to propylene glycol
US4250315A (en) Light-screening benzoxazole derivatives
US2102712A (en) Protective cosmetics
US3954989A (en) Topical compositions containing an allantoin ascorbic acid complex
US3472940A (en) Stable gelled alcohol compositions containing sodium acyl lactylates
CN106232089A (en) Skin protection cosmetics
CN114392205A (en) Microbead light sunscreen essence with sunscreen oil beads and preparation method thereof
JP2002534453A (en) Insect repellent and sunscreen combination composition
DE2617817A1 (en) ANTI-INFLAMMATORS FOR COSMETIC PREPARATIONS
JPH07145029A (en) Composition containing sun screen
JP2022531954A (en) Photoprotective system consisting of 4 sunscreen substances
WO1996030448A1 (en) Zinc oxide-coated body pigment and cosmetic material containing the same
JPS59172415A (en) Anti-suntan agent
Rathore et al. Development and evaluation of sunscreen cream containing benzophenone-3 microspheres for enhancing sunscreen activity
CN108096115B (en) Plant essence sunscreen cream and preparation method thereof
JPH0532531A (en) Cosmetic
US2418695A (en) Ultraviolet light filter composition
Groves The selection and evaluation of ultraviolet absorbers
KR20130055330A (en) Cosmetic composition for sunscreening gel comprising beads containing uv abosorbants or sunscreen
Rizkiyan et al. Nades Extract Of Gedong Mango Leaves And Mulberry Leaves In Spray Gel As A Sunscreen
Ashby Haematoporphyria congenita (congenital porphyrinuria); its association with hydroa vacciniforme and pigmentation of the teeth
DE2514878A1 (en) ALLANTOIN-ASCORBIC ACID COMPLEX